ECTRIMS/EAN publish new MS treatment guidelines


The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have published new guidelines on the use of disease-modifying drugs (DMDs) for multiple sclerosis (Montalban et al. Mult Scler 2018; epublished January 1, 2018; free full text at The groups identified 10 key questions, and issued a series of recommendations based on the level of evidence.

The following is a summary of the groups’ recommendations.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page